Výsledky vyhledávání - "TRINA PORETTA"

Akademický článek

Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors

Publikováno v: Cancer Medicine, Vol 10, Iss 13, Pp 4532-4541 (2021)

Abstract Purpose To examine the benefit of telehealth over current delivery options in oncology practices without genetic counselors. Methods Participants meeting cancer genetic testing guidelines were recruited to this multi‐center, randomized tri

Externí odkaz: https://doaj.org/article/eda538bc81684e22bb8ecc438ecbcee5

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma

Autor: Diane Check, Jerome H. Check, Carrie Wilson, Trina Poretta

Publikováno v: Anticancer Research. 41:2111-2115

Background/aim It has been hypothesized that many, or even most cancers, utilize a unique immunomodulatory protein, called the progesterone induced blocking factor (PIBF) to allow spread of the cancer. Support for this concept has been provided by ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7e810975af5df78870f1787acce0130
https://doi.org/10.21873/anticanres.14982

Zobrazit plný text záznamu

Abstract 3065: Increased longevity and quality of life with treatment with a progesterone receptor modulator in a patient with treatment resistant stage IV small cell lung cancer

Autor: Jerome H. Check, Carrie Wilson, Diane Check, Trina Poretta, Maya Srivastava

Publikováno v: Cancer Research. 83:3065-3065

The progesterone receptor modulator, mifepristone, has been found to provide extension of life by years and marked palliative benefits in several cases of non-small cell lung cancer (NSCLC) despite progression with platinum-based chemotherapy, check-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02aca3c50844fc24205cac09e77b30f5
https://doi.org/10.1158/1538-7445.am2023-3065

Zobrazit plný text záznamu

Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life

Autor: Maya D Srivastava, Diane Check, Jerome H. Check, Trina Poretta, James Aikins

Publikováno v: Anticancer Research. 40:6997-7001

Background There is evidence that a unique immunomodulatory protein, known as the progesterone induced blocking factor (PIBF), is utilized by a large variety of cancers to escape immune surveillance. Mifepristone, a progesterone receptor antagonist/m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab9413c4b7dc3eb6d604dc1fc31385d4
https://doi.org/10.21873/anticanres.14724

Zobrazit plný text záznamu

Abstract 1032: Progesterone receptor antagonist can provide marked palliative benefits and extend life by years in advanced lung cancer when no other treatment options are available

Autor: Jerome H. Check, Diane Check, Trina Poretta

Publikováno v: Cancer Research. 82:1032-1032

Metastatic lung cancer has a poor prognosis. The aim of chemotherapeutic agents, targeted therapies, or immunotherapies at this stage is to extend life and diminish suffering. Frequently the extension of life is for a few months, but amelioration of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3f3729f2dbc3cc50734781eb34819487
https://doi.org/10.1158/1538-7445.am2022-1032

Zobrazit plný text záznamu

Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor

Autor: Trina Poretta, Jerome H. Check, Diane Check

Publikováno v: Anticancer research. 39(4)

CASE REPORT Case 1 of an investigator-initiated study using oral single agent mifepristone to halt stage IV non-small cell lung cancer whose tumor was devoid of any targeted markers has remained ECOG zero and in good health for over 3 years. Case 2,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1033a9326fb6c77539976ff561cc5ec8
https://pubmed.ncbi.nlm.nih.gov/30952734

Zobrazit plný text záznamu

Abstract 695: Treatment with oral mifepristone enables a patient with end-stage pancreatic cancer in hospice, on a morphine drip, to restore a decent quality of life

Autor: Maya Srivastava, Diane Check, Carrie Wilson, James Aikins, Trina Poretta, Jerome H. Check

Publikováno v: Cancer Research. 80:695-695

The progesterone (P) receptor modulator, mifepristone, has been previously found to provide significant improvement in length and quality of life in people with a variety of advanced cancers. A 57 year old man with severe abdominal pain, dyspnea, nau

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ffd003a3e92e5c885aaa6a4aca67e9e
https://doi.org/10.1158/1538-7445.am2020-695

Zobrazit plný text záznamu

Abstract 697: Improvement in quality and length of life following treatment with mifepristone in women with stage IV non-small cell lung cancer, positive for the epidermal growth factor receptor (EGFR) mutation, that previously progressed on targeted therapy

Autor: Jerome H. Check, Trina Poretta, Diane Check, James Aikins, Carrie Wilson

Publikováno v: Cancer Research. 80:697-697

Treatment with the oral single agent progesterone receptor modulator, mifepristone, has been demonstrated to significantly increase the quality and length of life in a patient with stage IV non-small cell lung cancer (NSCLC) that progressed despite m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::536ccc054d64d28f7d1a430a78400e7a
https://doi.org/10.1158/1538-7445.am2020-697

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání